|
EP0044801B1
(de)
*
|
1980-07-17 |
1984-02-15 |
Josef Dr. Klosa |
Nichthygroskopische Salze der 4-Hydroxybuttersäure, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Mittel
|
|
ES2193777T3
(es)
|
1998-12-23 |
2003-11-01 |
Orphan Medical Inc |
Disoluciones estables e inalterables microbiologicamente de sal de gamma-hidroxibutirato para el tratamiento de la narcolepsia.
|
|
EP1316309A1
(en)
*
|
1998-12-23 |
2003-06-04 |
Orphan Medical Inc. |
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
|
|
US8778398B2
(en)
|
2008-11-04 |
2014-07-15 |
Jazz Pharmaceuticals, Inc. |
Immediate release formulations and dosage forms of gamma-hydroxybutyrate
|
|
US8771735B2
(en)
|
2008-11-04 |
2014-07-08 |
Jazz Pharmaceuticals, Inc. |
Immediate release dosage forms of sodium oxybate
|
|
CA2794171C
(en)
|
2010-03-24 |
2018-07-03 |
Jazz Pharmaceuticals, Inc. |
Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
|
|
US8591922B1
(en)
|
2012-12-14 |
2013-11-26 |
Jazz Pharmacuticals, Inc. |
Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
|
|
US9050302B2
(en)
|
2013-03-01 |
2015-06-09 |
Jazz Pharmaceuticals Ireland Limited |
Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
|
|
US10398662B1
(en)
|
2015-02-18 |
2019-09-03 |
Jazz Pharma Ireland Limited |
GHB formulation and method for its manufacture
|
|
US12186296B1
(en)
|
2016-07-22 |
2025-01-07 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
UY37341A
(es)
|
2016-07-22 |
2017-11-30 |
Flamel Ireland Ltd |
Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
|
|
US12478604B1
(en)
|
2016-07-22 |
2025-11-25 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US11602513B1
(en)
|
2016-07-22 |
2023-03-14 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US11986451B1
(en)
|
2016-07-22 |
2024-05-21 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US11504347B1
(en)
|
2016-07-22 |
2022-11-22 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US11602512B1
(en)
|
2016-07-22 |
2023-03-14 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US20180263936A1
(en)
|
2017-03-17 |
2018-09-20 |
Jazz Pharmaceuticals Ireland Limited |
Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
|
|
US11400052B2
(en)
|
2018-11-19 |
2022-08-02 |
Jazz Pharmaceuticals Ireland Limited |
Alcohol-resistant drug formulations
|
|
CN119868330A
(zh)
|
2019-03-01 |
2025-04-25 |
弗拉梅尔爱尔兰有限公司 |
在进食状态下具有改善的药代动力学的γ-羟基丁酸酯组合物
|
|
TW202139986A
(zh)
|
2020-02-21 |
2021-11-01 |
愛爾蘭商爵士製藥愛爾蘭有限責任公司 |
治療原發性嗜睡症之方法
|
|
US11779557B1
(en)
|
2022-02-07 |
2023-10-10 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US11583510B1
(en)
|
2022-02-07 |
2023-02-21 |
Flamel Ireland Limited |
Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
|